Old H1N1 Flu Vaccine Of Australia’s CSL Linked To Seven Deaths
This article was originally published in PharmAsia News
Executive Summary
Australian vaccine-maker CSL’s Panvax has been linked to seven deaths among 1,716 adverse events associated with the H1N1 drug.